Crinetics Pharmaceuticals, Inc. Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One
Crinetics Pharmaceuticals, Inc. (CRNX) had Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One of $752.17 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Notes › Debt and Equity Securities › Available-for-Sale Securities, Debt Maturities › Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Amortized Cost
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost · last filed 2026-08-03
- 2026-06-30: Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One $752.17M.
- 2026-03-31: Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One $718.48M.
- 2025-12-31: Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One $712.67M.
- 2025-09-30: Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One $765.93M.
| Period end | Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One | Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One as first filed |
|---|---|---|
| 2026-06-30 | $752.17M 10-Q · filed 2026-08-03 | |
| 2026-03-31 | $718.48M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $712.67M 10-Q · filed 2026-08-03 | |
| 2025-09-30 | $765.93M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $847.68M 10-Q · filed 2025-08-07 | |
| 2024-12-31 | $621.50M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $730.00M 10-Q · filed 2025-05-08 | $425.38M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $444.74M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $458.99M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $621.50M 10-Q · filed 2025-05-08 | $414.03M 10-K · filed 2024-02-28 |
| 2023-09-30 | $292.09M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $226.19M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $230.38M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $246.28M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $253.77M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $235.42M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $90.23M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $31.10M 10-K · filed 2023-02-28 | |
| 2020-12-31 | $59.47M 10-K · filed 2022-03-30 |